Health Care

Across the health care industry, companies are operating within a landscape defined by evolving regulation and increased need for risk management, mitigation, and sharing. Analysis Group has developed a detailed understanding of the health care sector and its unique institutional structure, market dynamics, and business and regulatory challenges.

We apply analytical expertise to litigation services and health care policy engagements and work on drug safety-related engagements in epidemiology. We draw on expertise in modeling and analytics to support our clients, which include major pharmaceutical manufacturers, biotech and medical device companies, payers, managed care organizations, and government agencies. In addition, our HEOR and Market Access teams develop strategies to support pharmaceutical products throughout their life cycles.

Our practice is distinguished by the way we integrate our capabilities in pharmacoeconomics, epidemiology, biostatistics, pricing and contracting strategies, data sourcing, and data science infrastructure to provide our clients with a comprehensive approach to problem solving.